Alex Levit - Feb 13, 2025 Form 4 Insider Report for Context Therapeutics Inc. (CNTX)

Role
Chief Legal Officer, Corp. Sec
Signature
/s/ Alex Levit, Attorney-in-Fact
Stock symbol
CNTX
Transactions as of
Feb 13, 2025
Transactions value $
$0
Form type
4
Date filed
2/14/2025, 04:11 PM
Previous filing
Mar 22, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNTX Stock Option (right to buy) Award $0 +350K $0.00 350K Feb 13, 2025 Common Stock 350K $0.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 13, 2026, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.